Oluwatosin Arubuolawe

PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin

Ibrahim L. Folorunsho, Nkechinyere Mary Harry, Chukwubueze Obiajunwa, Oluwatosin Arubuolawe, Adeniyi Kayode Busari, Chidalu Ibeneme & Gibson O. Anugwom · Journal of Advances in Medicine and Medical Research · 2024

Post-Traumatic Stress Disorder (PTSD) is a debilitating mental health condition that can occur after experiencing or witnessing a traumatic event. The impact of PTSD extends beyond the individual, affecting families, communities, and society as a whole. This study aims to investi...

Open access Research Article 10.9734/jammr/2024/v36i85525

The Effect of Employment-Based Contingency on Treatment Enrollment, Retention, and Long-Term Abstinence among Individuals with Substance use Disorder: A Systematic Review

Nkechinyere Mary Harry, Ibrahim Folorunsho, Nnenna Okafor, Oluwatosin Arubuolawe & Gibson Anugwom · Journal of Advances in Medicine and Medical Research · 2024

Background and Objective: Substance use disorders (SUD) remain a major public health concern and represent a significant cause of morbidity and mortality. Our goal in this study is to explore and determine the effect(s) of employment-based contingency (EBC) on enrolling SUD indiv...

Open access Research Article 10.9734/jammr/2024/v36i65455

Potential Role of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist in the Treatment of Bulimia Nervosa

Nkechinyere M. Harry, Kenechukwu Anona, Vivien O. Obitulata-Ugwu, Olubukola Anike Kuye, Oluwatosin Arubuolawe, Ibrahim L. Folorunsho, Adeniyi Kayode Busari, Chidalu Ibeneme, Amarachukwu Diala, Victory Afolabi & Gibson O. Anugwom · Journal of Advances in Medicine and Medical Research · 2024

Background: Bulimia nervosa (BN) is a severe eating disorder characterized by recurrent episodes of binge eating followed by compensatory behaviors such as self-induced vomiting, misuse of laxatives, fasting, or excessive exercise. Current treatment strategies, including cognitiv...

Open access Research Article 10.9734/jammr/2024/v36i75514

Intravenous Ketamine in the Treatment of Substance Use Disorder

Chidalu N. Ibeneme, Amarachukwu B. Diala, Victory Afolabi, Nkechinyere M. Harry, Kenechukwu Anona, Vivien O. Obitulata-Ugwu, Olubukola Anike Kuye, Oluwatosin Arubuolawe, Ibrahim Folorunsho, Adeniyi Kayode Busari, Chinelo Madekwe & Soji Ojo · Journal of Advances in Medicine and Medical Research · 2024

Background: Substance use disorders (SUD) represent a critical public health issue, significantly contributing to global morbidity and mortality. Traditional pharmacotherapies for SUD have limited efficacy, necessitating innovative treatment approaches. Ketamine, an N-methyl-D-as...

Open access Research Article 10.9734/jammr/2024/v36i105596